Zimmer Biomet (NYSE:ZBH) shares took a hit today as it lowered its guidance despite its third-quarter results beating The Street.
The Warsaw, Indiana-based company posted profits of $145.6 million, or 69¢ per share, on sales of more than $1.9 billion for the three months ended Sept. 30, 2021, for a 40% bottom-line slide on a sales decline of 0.3%.
